Longevity of antigen presentation and activation status of APC are decisive factors in the balance between CTL immunity versus tolerance

Journal of Immunology

Volumn 167, Issue 5, 2001, Pages 2522-2528

  Den Boer, A Th ^a   Diehl, L ^a   Van Mierlo, G J D ^a   Van der Voort, E I H ^a   Fransen, M F ^a   Krimpenfort, P ^a   Melief, C J M ^a   Offringa, R ^a   Toes, R E M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AD5E1A; AD5E1A PEPTIDE; CD40 ANTIGEN; EPITOPE; FGK 45; IMMUNOSTIMULATING AGENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD40; POLYINOSINIC POLYCYTIDYLIC ACID; UNCLASSIFIED DRUG; VACCINE; VIRUS PROTEIN;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EMBRYO; EPITOPE MAPPING; HUMAN; HUMAN ADENOVIRUS 5; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR GROWTH; VACCINATION;

EID: 0035451665     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.5.2522     Document Type: Article

References (35)

1. A fail-safe mechanism for maintaining self-tolerance
2. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: A geographical view of immune reactivity
3. + T cells
4. Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells
5. Role of antigen-presenting cells in mediating tolerance and autoimmunity
6. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
7. T cell priming versus T cell tolerance induced by synthetic peptides
8. T help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
9. Help for cytotoxic T cell responses is mediated by CD40 signalling
10. + T-helper and a T-killer cell
11. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
12. + T cell deletion induced by cross-presentation of seif-antigens and favors autoimmunity
13. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy
14. + cytotoxic T lymphocyte priming capacity upon activation by T helper cell -independent or -dependent stimuli
15. Antigen persistence and time of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection
16. + T cells to cause immunopathology
17. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures
18. Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction
19. Eradication of adenovirus E1-induced tumors by Ela-specific cytotoxic T lymphocytes
20. The SCID but not the RAG-2 gene product is required for the Sμ-Sε heavy chain class switching
21. Thermolubile DNA binding proteins from cells infected with a temperature-sensitive mutant of adenovrius defective in viral DNA synthesis
22. Vaccination with a cytotoxic T lymphocyte epitope -containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells
23. Phenotypic analysis of antigen-specific T lymphocytes
24. Systemic T cell expansion during localized viral infection
25. Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells
26. + T cells in vivo by IL-15
27. Polyriboinosinic polyribocytidylic acid (poly (I:C)) induces stable maturation of functionally active human dendritic cells
28. Murine experimental autoimmune hepatitis: Nonspecific inflammation due to adjuvant oil
29. + T cells in vivo by IL-15
30. Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy
31. A cell culture model for T lymphocyte clonal anergy
32. Priming of cytotoxic T lymphocytes by five heat-aggregated antigens in vivo: Conditions, efficiency, and relation to antibody responses
33. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with an unbound peptide
34. + T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained
35. Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence